These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35390220)

  • 1. Investigation on utility of some novel terpenes on transungual delivery of fluconazole for the management of onychomycosis.
    Adin SN; Gupta I; Ali A; Aqil M; Mujeeb M; Sultana Y
    J Cosmet Dermatol; 2022 Oct; 21(10):5103-5110. PubMed ID: 35390220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on Utility of Some Novel Terpenes on Transungual Delivery of Terbinafine for the Management of Onychomycosis.
    Gupta I; Adin SN; Aqil M; Mujeeb M; Sultana Y
    Dermatol Pract Concept; 2022 Nov; 12(4):e2022202. PubMed ID: 36534578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of monoterpenes on ex vivo transungual delivery of itraconazole for the management of onychomycosis.
    Abdollahi D; Jafariazar Z; Afshar M
    J Cosmet Dermatol; 2020 Oct; 19(10):2745-2751. PubMed ID: 32043759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
    Khattab A; Shalaby S
    AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of microemulgel formulations with varied permeation enhancers for transungual delivery of luliconazole in onychomycosis management.
    Giri Y; Habibullah S; Dixit PK; Mahalik G; Mohanty B; Behera A
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113718. PubMed ID: 38176335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
    Pal P; Thakur RS; Ray S; Mazumder B
    Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
    Palliyil B; Lebo DB; Patel PR
    AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
    Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
    Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ciclopirox nail lacquer with enhanced permeation and retention.
    Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
    Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and management strategies of onychomycosis.
    Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
    J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
    Rich P; Scher RK; Breneman D; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB; Hilbert J
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S103-9. PubMed ID: 9631992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.